RVTY vs VIVS · P/E 42, rev $1.44B vs P/E 0.7, rev $131.0K
Revvity Inc. (RVTY) versus VivoSim Labs, Inc. (VIVS) — a side-by-side from cached financials, not a winner call.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
VivoSim Labs, Inc. (VIVS) is a biotechnology company listed on NASDAQ.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Latest reported VIVS revenue for 2026-03-31 was $131.0K. Net income was -$13.8M. Revenue was down 9.0% from 2025-03-31 to 2026-03-31. VIVS currently screens at market cap $3.5M and trailing P/E 0.7.
RVTY currently screens at market cap $11.94B and trailing P/E 41.9. VIVS currently screens at market cap $3.5M and trailing P/E 0.7.
Not investment advice. Open the RVTY and VIVS stock pages for the full models.
Not investment advice.